Natalizumab (Tysabri) is a humanized monoclonal antibody against the cell adhesion molecule alpha4-integrin used in the treatment of multiple sclerosis and Crohns disease. Tysabri and was previously named Antegren. Natalizumab is administered by intra
* VAT and and shipping costs not included. Errors and price changes excepted